Anzeige
❌
Mehr »
Dienstag, 17.11.2026 - Börsentäglich über 12.000 News
GBC-Kursziel 2,00 CAD bis Juni 2027, Kurs 0,67 CAD: Verdreifachung drin?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QCDR | ISIN: US20451W1018 | Ticker: 5Y6
Tradegate
16.11.26 | 16:50
7,550 Euro
-7,93 % -0,650
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
COMPASS PATHWAYS PLC ADR Chart 1 Jahr
5-Tage-Chart
COMPASS PATHWAYS PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
7,4507,55016.11.
7,5507,65016.11.

Aktuelle News zur COMPASS PATHWAYS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiCompass Pathfinder Limited: Compass Pathways to Participate in Jefferies Global Healthcare Conference on November 18th and 19th584Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the Jefferies...
► Artikel lesen
09.11.Compass Pathways-Aktie legt nach FDA-Zulassungsantrag für Depressionsmedikament zu13
09.11.Jefferies reiterates Buy on Compass Pathways stock on TRD approval9
09.11.Compass Pathfinder Limited: Compass Pathways Completes COMP360 Psilocybin New Drug Application to U.S. FDA for Treatment-Resistant Depression544Robust NDA submission supported by data from two highly statistically significant Phase 3 trials and a Phase 2b study that each met its primary endpoint and involved a total of more than 1,000...
► Artikel lesen
05.11.Compass Pathfinder Limited: Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)390Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards...
► Artikel lesen
05.11.Compass Pathways (NDQ:CMPS): Can Psychedelic Therapy Become Mainstream Medicine? If So, This Company Is Well Poised To Win!10
04.11.Stifel reiterates Compass Pathways stock rating amid competition30
COMPASS PATHWAYS Aktie jetzt für 0€ handeln
03.11.Oppenheimer reiterates Compass Pathways stock rating on NDA filing9
03.11.Compass Pathways: TD Cowen bekräftigt Kaufempfehlung vor Einreichung des Zulassungsantrags (NDA)13
03.11.Compass Pathways stock maintained at Buy by TD Cowen ahead of NDA filing3
03.11.Compass Pathways outlines potential 30- to 60-day FDA review target as it plans to complete COMP360 NDA in next 2 weeks8
03.11.Compass Pathways stock rating reiterated at Buy by BTIG28
03.11.Stifel reiterates Compass Pathways stock rating on NDA progress6
03.11.COMPASS Pathways rebounds on earnings after selloff driven by rival's NDA submission10
03.11.COMPASS Pathways plc - 8-K, Current Report4
03.11.COMPASS Pathways plc - 10-Q, Quarterly Report5
03.11.COMPASS Pathways ADS GAAP EPS of -$0.31 beats by $0.1018
03.11.Compass Pathfinder Limited: Compass Pathways Announces Third Quarter 2026 Financial Results and Business Highlights375Final NDA submission nearing completion and will be filed in the next two weeks Launch readiness on track for expected launch in H12027, subject to FDA approval Data from two positive...
► Artikel lesen
02.11.Compass Pathfinder Limited: New Joint Survey from Compass Pathways and the Depression and Bipolar Support Alliance Reveals the Lived Burden of Treatment-Resistant Depression on Patients and Caregivers468New survey findings reveal the extent of unmet need for people living with treatment-resistant depression (TRD) and its impact on families, relationships and the ability to participate fully in...
► Artikel lesen
02.11.1 Reason Compass Pathways Is Worth a Second Look This Month32
1 2 3 4 5 Weiter >>
127 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,5